SCHEMBL13633903

SCHEMBL13633903

CCc1nc(-c2cccnc2)oc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
KDM4E B2RXH2 7/20 0.50
HSD17B10 Q99714 5/20 0.50
NPC1 O15118 5/20 0.50
RAB9A P51151 5/20 0.50
HPGD P15428 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2C19 P33261 2/20 0.50
TP53 P04637 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
ELANE P08246 1/20 0.47
TSHR P16473 2/20 0.46
CHRNB2 P17787 1/20 0.45
CHRNA5 P30532 1/20 0.45
CHRNA4 P43681 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4415685 0.86 NPC1 (0.49) ALDH1A1KDM4EHSD17B10NPC1RAB9A
SCHEMBL266619 0.82 KDM4E (0.66) KDM4ENPC1RAB9AHPGDTP53
SCHEMBL4030129 0.81 KDM4E (0.74) ALDH1A1KDM4EHSD17B10NPC1RAB9A
SCHEMBL27630799 0.80 KDM4E (0.57) ALDH1A1KDM4EHSD17B10NPC1RAB9A
SCHEMBL1803772 0.80 ALDH1A1 (0.55) ALDH1A1KDM4EHSD17B10NPC1RAB9A
SCHEMBL8518294 0.80 USP2 (0.48) ALDH1A1KDM4EHSD17B10NPC1RAB9A
Lithium Ion SCHEMBL5832915 0.79 KDM4E (0.71) ALDH1A1KDM4EHSD17B10NPC1RAB9A
SCHEMBL1803771 0.78 NPC1 (0.52) ALDH1A1KDM4EHSD17B10NPC1RAB9A
SCHEMBL3580551 0.77 PPARG (0.50) ALDH1A1KDM4ENPC1RAB9ATP53
SCHEMBL6568991 0.76 KDM4E (0.59) KDM4ENPC1RAB9AHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275565-A1 Substituted aralkyl derivatives CADILA HEALTHCARE LIMITED (IN) 2009-11-05 US disclosed
US-20090275565-A1 Substituted aralkyl derivatives CADILA HEALTHCARE LIMITED (IN) 2009-11-05 US disclosed
EP-1569916-B1 SUBSTITUTED ARALKYL DERIVATIVES CADILA HEALTHCARE LTD (IN) 2009-01-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275565-A1 Substituted aralkyl derivatives UGT1A7, UGT1A10, UGT2B7 ALDH1A1 1255/4885KDM4E 4614/4885HSD17B10 1053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.